Core Laboratories
CLB
304 hedge funds and large institutions have $2.43B invested in Core Laboratories in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 105 increasing their positions, 100 reducing their positions, and 60 closing their positions.
5% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 100
0.72% more ownership
Funds ownership: 104.34% → 105.06% (+0.72%)
3% less funds holding
Funds holding: 313 → 304 (-9)
10% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 60
24% less capital invested
Capital invested by funds: $3.19B → $2.43B (-$754M)
35% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $28.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$61.1M |
| 2 |
VanEck Associates
New York
|
+$42.1M |
| 3 |
MNG
Manning & Napier Group
Fairport,
New York
|
+$40.3M |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$22.9M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$215M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29.4M |
| 3 |
Lazard Asset Management
New York
|
-$27.3M |
| 4 |
ClearBridge Investments
New York
|
-$24.2M |
| 5 |
Renaissance Technologies
New York
|
-$17.3M |
CLB Hedge Fund Activity: Q2 2019 in Review
304 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2019, worth a combined $2.43B — down 24% from $3.19B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of CLB and 54 opened new positions — a net loss of 6 holders — while 100 trimmed existing stakes and 105 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $61.1M. The largest seller was WCM Investment Management, exiting entirely with an estimated $215M sold.
- 304 institutional investors held Core Laboratories (CLB) as of Q2 2019, down from 313 in Q1 2019.
- Funds reported $2.43B of Core Laboratories stock for Q2 2019, down 24% quarter-over-quarter.
- 54 funds opened new Core Laboratories positions in Q2 2019 and 60 closed out, a net change of -6 holders.
- The largest Core Laboratories buyer in Q2 2019 was Massachusetts Financial Services, an estimated $61.1M added.
- The largest Core Laboratories seller in Q2 2019 was WCM Investment Management, an estimated $215M sold.
Based on aggregated 13F filings for Q2 2019.